BioSpace News Archive

Drug Development

John Theurer Cancer Center Release: International Clinical Trial Suggests Value Of Venetoclax Combination Therapy In Patients With B-Cell Non-Hodgkin Lymphoma

June 6, 2016
·
4 min read
Lone Star Bio

The Dallas PRP and Stem Cell Institute Announces New Arthritis Treatment Study

June 6, 2016
·
1 min read
Business

Seres Therapeutics Announces Research Collaboration With Mayo Clinic To Identify Microbiome Therapeutics For Primary Sclerosing Cholangitis, Non-Alcoholic Steatohepatitis (NASH) And Other Liver Diseases

June 6, 2016
·
7 min read
Health For Life Capital Participates In $50m Financing Of Microbiome Company Vedanta Biosciences

June 6, 2016
·
5 min read
Drug Development

Long-Term Data From Two Trials Evaluating The Opdivo (Nivolumab) And Yervoy (Ipilimumab) Regimen In Advanced Melanoma Continues To Validate Bristol-Myers Squibb’s Immuno-Oncology Combination Approach

June 6, 2016
·
20 min read
FDA

Axonics Modulation Tech Receives CE Mark For Its Sacral Neuromodulation System For The Treatment Of Urinary And Fecal Dysfunction

June 6, 2016
·
4 min read
Lone Star Bio

Moleculin Release: Annamycin: A New Hope For AML Patients

June 6, 2016
·
7 min read
BioMidwest

Oklahoma Bioscience Association To Exhibit At 2016 BIO International Convention

June 6, 2016
·
1 min read
Drug Development

ASCO2016: OBI Pharma Presents Data For Novel Investigational OBI-822/OBI-821 In Patients With Metastatic Breast Cancer At The 2016 American Society Of Clinical Oncology Annual Meeting

June 6, 2016
·
4 min read
Biotech Beach

Presence Of AR-V7 In Circulating Tumor Cells Validated As Predictive Biomarker For Advanced Prostate Cancer Treatment By Memorial Sloan-Kettering Cancer Center And Epic Sciences

June 6, 2016
·
5 min read